Improving recording of capacity to consent and explanation of medication side effects in a psychiatric service for people with learning disability: Audit findings

Journal of Intellectual Disabilities

Volumn 15, Issue 2, 2011, Pages 85-92

  Roy, Ashwin ^a   Jain, Sarus ^b   Roy, Ameeta ^c   Ward, Frances ^d,e   Richings, Ceri ^f   Martin, Mark ^e   Roy, Meera ^e  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d St Stephens Centre   (United Kingdom)

^e Birmingham Community Healthcare NHS Trust ^*  (United Kingdom)

^f NONE

Author keywords

capacity; consent; recording; rubber stamp; side effects

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DEVICE; DRUG INDUCED DISEASE; DRUG INFORMATION; HUMAN; INFORMED CONSENT; LEARNING DISORDER; MEDICAL AUDIT; MEDICAL DOCUMENTATION; MENTAL CAPACITY; PATIENT DECISION MAKING; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRIST; RECORDING; RUBBER STAMP;

AMBULATORY CARE; CONSENT FORMS; HEALTH RECORDS, PERSONAL; HUMANS; INFORMED CONSENT; LEARNING DISORDERS; MENTAL COMPETENCY; PSYCHIATRY; URBAN POPULATION;

EID: 80052364110     PISSN: 17446295     EISSN: 17446309     Source Type: Journal    
DOI: 10.1177/1744629511410826     Document Type: Article

References (13)

1. Arscott K., Dagnan D. and Kroese B. (1999) Assessing the ability of people with a learning disability to give informed consent to treatment. Psychological Medicine 29 (6). 1367-1375.
2. Curran J. and Hollins S. (1994) Consent to medical treatment and people with learning disability. Psychiatric Bulletin 18 (11). 691-693.
3. Deb S., Sohanpal SK, Soni R., Lenotre L. and Unwin G. (2007) The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disability. Journal of Intellectual Disability Research 51 (10). 766-777. (Pubitemid 47371838)
4. Deb S., Kwok H., Bertelli M., Salvador-Carulla L., Bradley E., Torr J. and Barnhill J., for the Guideline Development Group of the WPA Section on Psychiatry of Intellectual Disability (2009) International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities. World Psychiatry 8 (3). 181-186.
5. Dyer C. (1989) Law Lords give reasons for their decision on consent. British Medical Journal 298: 1542. F v. West Berkshire Health Authority (1989) 2 All ER 545.
6. General Medical Council (2008) Consent: Patients and Doctors Making Decisions Together.
7. Goldsmith L., Skirton H. and Webb C. (2008) Informed consent to healthcare interventions in people with learning disabilities: an integrative review. Journal of Advanced Nursing 64 (6). 549-563.
8. Haw C. and Stubbs J. (2005) A survey of off label prescribing for patients with mild intellectual disability and mental illness. Journal of Intellectual Disability Research 49 (11). 858-864. (Pubitemid 41600769)
9. Holden B. and Gitlesen JP (2004) Psychotropic medication in adults with mental retardation: prevalence and prescription practices. Research in Developmental Disabilities 48 (6). 556-562.
10. Laugharne J., Arcelsus J. and Davies A. (1996) Consent to treatment. British Journal of Psychiatry 169 (3). 382.
11. Raghavan R. and Patel P. (2010) Ethical issues of psychotropic medication for people with intellectual disabilities. Advances in Mental Health and Intellectual Disabilities 4 (3). 34-38.
12. Schachter D. and Kleinman I. (2006) Psychiatrists' documentation of informed consent: a representative survey. Canadian Journal of Psychiatry 51 (7). 438-444. (Pubitemid 44065745)
13. Unwin GL and Deb S. (2007) A multicentre audit of the use of medication for the management of behavioural problems in adults with intellectual disabilities. British Journal of Learning Disabilities 36 (2). 140-143.